← All trials
NCT04780438
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2021
- Primary completion
- Sep 1, 2023
- Completion date
- Dec 1, 2023
- First posted
- Mar 3, 2021
- Last posted
- Jul 27, 2021
- Enrollment
- 350
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Gennimatas Hospital, AthensLead sponsor
- Gennimatas Hospital, AthensReponsible party - principal investigator
- University of AthensCollaborator
- University of AthensOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.